# Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

> **NCT03739372** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 44 (estimated)

## Conditions studied

- Glioma
- Glioma of Brain
- Cancer
- Pediatric Cancer
- Pediatric Brain Tumor
- Astrocytoma
- Glioblastoma
- Hemispheric

## Interventions

- **OTHER:** Specialized tumor board recommendation

## Key facts

- **NCT ID:** NCT03739372
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-11-28
- **Primary completion:** 2023-12-31
- **Final completion:** 2027-01-01
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2025-07-11

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03739372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03739372, "Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03739372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*